OpenSAFELY Vaccine Coverage Report

First dose / Priority Group 1

Data from combined, up to 2021-03-20.

Vaccinated at 2021-03-20 (%) Vaccinated at 2021-03-20 (n) Population Vaccinated at 2021-03-13 (%) Vaccinated in past week (%)
Overall - 91.5% 276,283 302,092 90.9% 0.6%
Sex Female 93.2% 178,822 191,842 92.8% 0.4%
Male 88.4% 97,461 110,250 87.5% 0.9%
Ethnicity White - British 92.4% 177,681 192,220 91.8% 0.6%
White - Irish 92.2% 2,310 2,506 91.6% 0.6%
White - Any other White background 82.4% 5,194 6,300 81.7% 0.8%
Mixed - White and Black Caribbean 73.3% 441 602 70.9% 2.3%
Mixed - White and Black African 63.9% 161 252 63.9% 0.0%
Mixed - White and Asian 82.4% 196 238 79.4% 2.9%
Mixed - Any other mixed background 79.4% 378 476 77.9% 1.5%
Asian or Asian British - Indian 86.2% 1,792 2,079 85.9% 0.3%
Asian or Asian British - Pakistani 73.0% 644 882 70.6% 2.4%
Asian or Asian British - Bangladeshi 78.0% 322 413 78.0% 0.0%
Asian or Asian British - Any other Asian background 81.2% 966 1,190 79.4% 1.8%
Black or Black British - Caribbean 74.0% 1,694 2,289 72.8% 1.2%
Black or Black British - African 69.7% 980 1,407 67.2% 2.5%
Black or Black British - Any other Black background 71.3% 539 756 68.5% 2.8%
Other ethnic groups - Chinese 84.0% 294 350 84.0% 0.0%
Other ethnic groups - Any other ethnic group 77.8% 910 1,169 76.6% 1.2%
Patients with any other ethnicity code 92.0% 35,875 39,004 91.4% 0.6%
Ethnicity not stated 91.1% 2,499 2,744 90.6% 0.5%
Ethnicity not recorded 92.0% 43,337 47,089 91.6% 0.4%
Ethnicity (broad categories) White 92.1% 185,185 201,040 91.5% 0.6%
Mixed 74.0% 1,176 1,589 72.7% 1.3%
South Asian 81.8% 3,745 4,578 80.6% 1.2%
Black 71.9% 3,213 4,466 70.5% 1.4%
Other 79.4% 1,211 1,526 78.4% 0.9%
Unknown 92.0% 81,718 88,851 91.5% 0.5%
Index of Multiple Deprivation 1 (most deprived) 89.3% 54,432 60,921 88.7% 0.7%
2 90.3% 56,952 63,070 89.5% 0.8%
3 92.0% 58,485 63,567 91.4% 0.6%
4 92.8% 56,196 60,571 92.3% 0.5%
5 (least deprived) 93.4% 48,629 52,087 93.0% 0.4%
Unknown 85.2% 1,568 1,841 84.4% 0.8%
Clinical Risk Groups Patients in Any Clinical Risk Group 92.4% 240,947 260,827 91.8% 0.6%
Patients with Immunosuppression 92.9% 8,582 9,233 92.4% 0.5%
Patients with CKD 95.1% 71,827 75,523 94.8% 0.4%
Patients who have Chronic Respiratory Disease 93.5% 26,145 27,965 93.0% 0.5%
Patients with Diabetes 92.9% 53,088 57,120 92.4% 0.5%
Patients with Chronic Liver disease 89.1% 7,056 7,917 88.2% 0.9%
Patients with CNS Disease (including Stroke/TIA) 93.4% 143,213 153,412 92.9% 0.5%
Patients with Chronic heart disease 94.3% 102,683 108,871 93.9% 0.4%
Patients with Asplenia or Dysfunction of the Spleen 92.4% 2,142 2,317 91.8% 0.6%
Patients with Wider Learning Disability 88.1% 40,012 45,395 86.8% 1.3%
Patients with Severe Mental Health 85.4% 25,767 30,177 84.3% 1.0%
Other Groups Patients who are shielding (High Risk from COVID-19) 94.4% 200,039 211,855 94.1% 0.3%
Patients with Morbid Obesity 87.9% 7,189 8,176 86.7% 1.2%
Patients who are pregnant 42.9% 63 147 42.9% 0.0%